An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B
Clinical trial NCT02213250 · COMPLETED
Trial details
- NCT number
- NCT02213250
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.